Results 231 to 240 of about 798,697 (287)

Correction: Production and characterization of breadfruit flour (<i>Artocarpus altilis</i>): an alternative for the elaboration of flakes for children's alimentation. [PDF]

Front Nutr
Arteaga C, Arias-Gutiérrez R, Rodríguez A, Heredia-Aguirre S, Gozalbo M, Blesa J, Alvarado-Barba RA, Ríos-Romero CG, Villavicencio Barriga D, Vásquez J, Egas K, Quiroga-Torres E, Bustillos A, Carpio-Arias TV.   +13 more
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Out of the box: toward new frameworks for understanding human microbiomes. [PDF]

mSphere
Kozik AJ.
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Antecedents of the effectiveness of entrepreneurship policy: An integrated framework. [PDF]

PLoS One
Zhang M, Zhang W.
europepmc   +1 more source

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz, Ryan Cooper, Stefania Kaninia, Kathryn I. Challis, Will Greenway, Maria Bonello, Mahmoud Elbahnasawi, Deborah T. Shode, Dominika Gajdasik, Victor Iliev, Alison M. E. Whitelegg, Ian Galea   +11 more
wiley   +1 more source

The Young Adult Sleep model: an evolving causal loop diagram of mental health dynamics. [PDF]

BMC Med
Uleman JF, Al-Shama RFM, Zucco AG, Echterhoff J, Luijten M, Verhagen M, Vyrastekova J, Treur JL, Wootton RE, Jones S, Dresler M, Drews HJ, Egebjerg C, Kornum BR, Stronks K, Rod NH.   +15 more
europepmc   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Correction for Singer, Confronting the inevitable: Harnessing technology to contain systemic scientific fraud. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Scientific communication and vaccine hesitation: an analysis of the editorial line of a great Brazilian newspaper. [PDF]

Oxf Open Immunol
Silva HM.
europepmc   +1 more source